C12Y 301/25001
Deoxyribonuclease
Official title: Deoxyribonuclease (pyrimidine dimer)(3.1.25.1)
C12Y301/25001 (Deoxyribonuclease) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 5
- Assignees
- 4
- Inventors
- 14
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 2 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations20 Jan 2026US 12,529,100 B2Roche Sequencing Solutions, Inc.
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations6 Dec 2022US 11,519,026 B2Roche Sequencing Solutions, Inc.
- Sequence-specific in vivo cell targeting8 Nov 2022US 11,491,208 B2Gflas Life Sciences, Inc.
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations9 Mar 2023US 2023/0074210 A1Roche Sequencing Solutions, Inc.
- Sequence-specific in vivo cell targeting6 Oct 2022US 2022/0313796 A1Gflas Life Sciences, Inc.
- Sequence-specific in vivo cell targeting18 Mar 2021US 2021/0077594 A1G+FLAS Life Sciences
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations30 May 2019US 2019/0161794 A1Roche Sequencing Solutions, Inc.
- Use of DNA repair enzymes as MMP 1 inhibitors4 Dec 2003US 2003/0223982 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.